SCHEMBL20069680

SCHEMBL20069680

CN1CCC(C)(C(=O)NCC2CCOCC2)CC1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.38
ALDH1A1 P00352 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
CYP3A4 P08684 2/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 2/20 0.36
HRH3 Q9Y5N1 1/20 0.36
NAMPT P43490 3/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
KMT2A Q03164 1/20 0.34
CTSS P25774 2/20 0.34
CTSL P07711 1/20 0.34
POLB P06746 1/20 0.33
CCR2 P41597 1/20 0.33
HTR4 Q13639 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20069779 0.90 CYP3A4 (0.44) RETALDH1A1SMN1; SMN2CYP3A4HPGD
SCHEMBL20206025 0.85 HRH3 (0.39) RETALDH1A1SMN1; SMN2CYP3A4HPGD
SCHEMBL20069154 0.84 RET (0.41) RETALDH1A1MAPK1NAMPTKMT2A
SCHEMBL18377462 0.82 CYP3A4 (0.42) ALDH1A1SMN1; SMN2CYP3A4HPGDMAPK1
SCHEMBL20069676 0.78 TSHR (0.52) ALDH1A1SMN1; SMN2HPGDKDM4EMEN1
SCHEMBL22172283 0.76 KMT2A (0.41) ALDH1A1KDM4EKMT2A
SCHEMBL20148017 0.76 SMN1; SMN2 (0.43) RETALDH1A1SMN1; SMN2CYP3A4HPGD
SCHEMBL20158498 0.74 SMN1; SMN2 (0.43) RETALDH1A1SMN1; SMN2CYP3A4HPGD
SCHEMBL19198339 0.73 EPHX1 (0.44) ALDH1A1SMN1; SMN2CYP3A4HPGDNPC1
SCHEMBL20158595 0.72 RET (0.41) RETALDH1A1SMN1; SMN2CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018071454-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed